GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is offering free online ...

GoodRx returned to sequential growth in subscribers in Q3, showing potential for profit improvement. Read why I upgrade GDRX ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

Santa Monica-based prescription drug savings platform GoodRx Holdings Inc. has hired a pharmacy benefits industry veteran as ...

Analysts have set 12-month price targets for GoodRx Holdings, revealing an average target of $6.25, a high estimate of $7.00, ...

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets ...

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

Courtesy of Business Wire/GoodRx She joins GoodRx from RxBenefits, which calls itself a pharmacy benefits optimizer, consulting with self-insured employers on pharmacy benefits. Barnes also ...

GoodRx operates a platform that aggregates prescription drug prices from pharmacy benefit managers (PBMs) and pharmacies, offering consumers access to discounted medications. The company has ...

Wendy will join GoodRx following her role as CEO of RxBenefits, where she led the company in providing pharmacy benefit support to more than 2,000 self-insured clients comprised of more than three ...